Promotion of Cellular and Humoral Immunity against Foot-and-Mouth Disease Virus by Immunization with Virus-Like Particles Encapsulated in Monophosphoryl Lipid A and Liposomes.

TLR4 agonist foot-and-mouth disease immunogenicity liposome vaccine virus-like particles

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
31 Oct 2020
Historique:
received: 25 09 2020
revised: 29 10 2020
accepted: 30 10 2020
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 5 11 2020
Statut: epublish

Résumé

Virus-like particles (VLPs) have emerged as promising vaccine candidates against foot-and-mouth disease (FMD). However, such vaccines provide a relatively low level of protection against FMD virus (FMDV) because of their poor immunogenicity. Therefore, it is necessary to design effective vaccine strategies that induce more potent immunogenicity. In order to investigate the means to improve FMD VLP vaccine (VLP

Identifiants

pubmed: 33142799
pii: vaccines8040633
doi: 10.3390/vaccines8040633
pmc: PMC7712044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Clin Exp Allergy. 2003 Sep;33(9):1198-208
pubmed: 12956739
Plant Biotechnol J. 2008 Jun;6(5):427-41
pubmed: 18422886
Res Vet Sci. 2013 Dec;95(3):1217-23
pubmed: 23969204
NPJ Vaccines. 2017 Sep 8;2:25
pubmed: 29263880
Curr Opin Immunol. 2014 Jun;28:58-63
pubmed: 24608070
Virology. 2017 Feb;502:123-132
pubmed: 28039799
J Virol. 2014 Feb;88(3):1819-24
pubmed: 24227857
J Nanobiotechnology. 2017 Nov 17;15(1):83
pubmed: 29149896
Vaccine. 2015 Jan 29;33(5):693-700
pubmed: 25500306
BMC Biotechnol. 2016 Jul 02;16(1):56
pubmed: 27371162
Immunol Lett. 2009 Aug 15;125(2):79-85
pubmed: 19539648
Vaccine. 2001 Apr 30;19(23-24):3301-10
pubmed: 11312029
PLoS One. 2010 Mar 22;5(3):e9784
pubmed: 20339535
Structure. 1995 Jun 15;3(6):571-80
pubmed: 8590018
Vaccine. 2014 Jan 23;32(5):631-8
pubmed: 24035435
BMC Vet Res. 2019 Jan 25;15(1):38
pubmed: 30683105
Expert Rev Vaccines. 2017 Jan;16(1):55-63
pubmed: 27448771
Clin Exp Vaccine Res. 2013 Jan;2(1):8-18
pubmed: 23596585
Vaccine. 2017 Jul 5;35(31):3865-3874
pubmed: 28596090
Infect Immun. 2005 Sep;73(9):5817-26
pubmed: 16113300
Front Immunol. 2019 Oct 29;10:2509
pubmed: 31736952
Microb Pathog. 2018 Dec;125:84-92
pubmed: 30195646
Hum Vaccin Immunother. 2017 Sep 2;13(9):2098-2101
pubmed: 28272979
Saudi Pharm J. 2011 Oct;19(4):197-206
pubmed: 23960760
Clin Immunol. 2017 Oct;183:99-108
pubmed: 28780375
Vaccines (Basel). 2020 Mar 20;8(1):
pubmed: 32244935
J Gen Virol. 2013 Jan;94(Pt 1):97-107
pubmed: 23034593
Mucosal Immunol. 2009 Sep;2(5):403-11
pubmed: 19587639
Korean J Food Sci Anim Resour. 2018 Dec;38(6):1155-1159
pubmed: 30675107
J Anim Sci Technol. 2015 Apr 01;57:10
pubmed: 26290730
Biologicals. 2015 Nov;43(6):437-43
pubmed: 26493006
Skin Therapy Lett. 2019 Jul;24(4):5-7
pubmed: 31339679
Int J Mol Sci. 2018 Sep 23;19(10):
pubmed: 30249040
Cytokine Growth Factor Rev. 2010 Dec;21(6):443-8
pubmed: 21095154
Clin Microbiol Rev. 2004 Apr;17(2):465-93
pubmed: 15084510
Vet Res. 2013 Dec 05;44:116
pubmed: 24308718
Appl Biochem Biotechnol. 2017 Sep;183(1):318-331
pubmed: 28281181
Sci Rep. 2019 Jun 25;9(1):9251
pubmed: 31239471
Infect Immun. 2000 Feb;68(2):791-5
pubmed: 10639447
Expert Rev Vaccines. 2012 Apr;11(4):481-93
pubmed: 22551033
J Virol. 2010 Dec;84(23):12375-84
pubmed: 20861264
Nat Med. 2007 Jul;13(7):843-50
pubmed: 17558415
Infect Immun. 1998 Jun;66(6):2859-65
pubmed: 9596760
Pharm Res. 2011 Mar;28(3):553-62
pubmed: 21042837
Vet Microbiol. 2009 May 28;137(1-2):10-7
pubmed: 19167843
Expert Rev Vaccines. 2018 Sep;17(9):833-849
pubmed: 30173619
Blood. 2006 Jun 15;107(12):4781-9
pubmed: 16467198
Adv Exp Med Biol. 2010;667:111-23
pubmed: 20665204
Rev Sci Tech. 2012 Dec;31(3):907-18
pubmed: 23520744
Vaccines (Basel). 2019 Aug 16;7(3):
pubmed: 31426368
Theranostics. 2012;2(11):1092-103
pubmed: 23227125
Vet Res. 2013 Jul 04;44:48
pubmed: 23826638
Front Microbiol. 2018 Nov 12;9:2644
pubmed: 30483224

Auteurs

Woo Sik Kim (WS)

Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup 56212, Korea.

Yong Zhi (Y)

Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup 56212, Korea.
Department of Radiation Science, University of Science and Technology, Daejeon 34057, Korea.

Huichen Guo (H)

State Key Laboratory of Veterinary Etiological Biology, National Foot and Mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China.

Eui-Baek Byun (EB)

Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup 56212, Korea.

Jae Hyang Lim (JH)

Department of Microbiology, Ewha Womans University College of Medicine, Seoul 03760, Korea.
Ewha Education & Research Center for Infection, Ewha Womans University Medical Center, Seoul 03760, Korea.

Ho Seong Seo (HS)

Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup 56212, Korea.
Department of Radiation Science, University of Science and Technology, Daejeon 34057, Korea.

Classifications MeSH